Validation of a two-step quality control approach for a large-scale human urine metabolomic study conducted in seven experimental batches with LC/QTOF-MS.

After his study of food science at the Rheinische Friedrich-Wilhelms University of Bonn, Tobias J Demetrowitsch obtained his doctoral degree in the research field of metabolomics at the Christian-Albrechts-University of Kiel. The present paper is part of his doctoral thesis and describes an extended strategy to evaluate and verify complex or large-scale experiments and data sets. Large-scale studies result in high sample numbers, requiring the analysis of samples in different batches. So far, the verification of such LC-MS-based metabolomics studies is difficult. Common approaches have not provided a reliable validation procedure to date. This article shows a novel verification process for a large-scale human urine study (analyzed by a LC/QToF-MS system) using a two-step validation procedure. The first step comprises a targeted approach that aims to examine and exclude statistical outliers. The second step consists of a principle component analysis, with the aim of a tight cluster of all quality controls and a second for all volunteer samples. The applied study design provides a reliable two-step validation procedure for large-scale studies and additionally contains an inhouse verification procedure.

[1]  Philippe Schmitt-Kopplin,et al.  Doping Control Using High and Ultra-High Resolution Mass Spectrometry Based Non-Targeted Metabolomics-A Case Study of Salbutamol and Budesonide Abuse , 2013, PloS one.

[2]  Wolfgang Völkel,et al.  Metabonomics and biomarker discovery: LC-MS metabolic profiling and constant neutral loss scanning combined with multivariate data analysis for mercapturic acid analysis. , 2006, Analytical chemistry.

[3]  I. Wilson,et al.  Evaluation of the repeatability of ultra-performance liquid chromatography-TOF-MS for global metabolic profiling of human urine samples. , 2008, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[4]  Lyle Burton,et al.  Investigation of analytical variation in metabonomic analysis using liquid chromatography/mass spectrometry. , 2007, Rapid communications in mass spectrometry : RCM.

[5]  Gordana Ivosev,et al.  Dimensionality reduction and visualization in principal component analysis. , 2008, Analytical chemistry.

[6]  David S. Wishart,et al.  HMDB: a knowledgebase for the human metabolome , 2008, Nucleic Acids Res..

[7]  Vic Barnett,et al.  Outliers in Statistical Data , 1980 .

[8]  J. Orduna,et al.  Non-targeted metabolomic approach reveals urinary metabolites linked to steroid biosynthesis pathway after ingestion of citrus juice. , 2013, Food chemistry.

[9]  I. Wilson,et al.  Within-day reproducibility of an HPLC-MS-based method for metabonomic analysis: application to human urine. , 2007, Journal of proteome research.

[10]  David S. Wishart,et al.  HMDB 3.0—The Human Metabolome Database in 2013 , 2012, Nucleic Acids Res..

[11]  David Broadhurst,et al.  The importance of experimental design and QC samples in large-scale and MS-driven untargeted metabolomic studies of humans. , 2012, Bioanalysis.

[12]  Pierre Marquet,et al.  LC-MS/MS systematic toxicological analysis: comparison of MS/MS spectra obtained with different instruments and settings. , 2005, Clinical biochemistry.

[13]  Joshua D. Knowles,et al.  Development of a robust and repeatable UPLC-MS method for the long-term metabolomic study of human serum. , 2009, Analytical chemistry.

[14]  R. Bischoff,et al.  Comparative urine analysis by liquid chromatography-mass spectrometry and multivariate statistics: method development, evaluation, and application to proteinuria. , 2007, Journal of proteome research.

[15]  I. Wilson,et al.  A QC approach to the determination of day-to-day reproducibility and robustness of LC-MS methods for global metabolite profiling in metabonomics/metabolomics. , 2012, Bioanalysis.

[16]  Ying Zhang,et al.  HMDB: the Human Metabolome Database , 2007, Nucleic Acids Res..

[17]  B. Warrack,et al.  Normalization strategies for metabonomic analysis of urine samples. , 2009, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[18]  Terence P. Speed,et al.  A comparison of normalization methods for high density oligonucleotide array data based on variance and bias , 2003, Bioinform..

[19]  E. Want,et al.  HILIC-UPLC-MS for exploratory urinary metabolic profiling in toxicological studies. , 2011, Analytical chemistry.

[20]  U. Fauth,et al.  Determination of Ascorbic Acid in Plasma and Urine by High Performance Liquid Chromatography with Ultraviolet Detection , 1999, Clinical chemistry and laboratory medicine.

[21]  I. Wilson,et al.  A pragmatic and readily implemented quality control strategy for HPLC-MS and GC-MS-based metabonomic analysis. , 2006, The Analyst.

[22]  C. Kies,et al.  Urinary ascorbic acid excretion in the human as affected by dietary fiber and zinc. , 1978, The American journal of clinical nutrition.

[23]  A. Materny,et al.  Scope and limitations of principal component analysis of high resolution LC-TOF-MS data: the analysis of the fraction in green coffee beans as a case study. , 2011, Analytical methods : advancing methods and applications.